News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020
News Daily News Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE Michael O'Riordan July 08, 2020
News Daily News Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response L.A. McKeown June 25, 2020
News Daily News Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension L.A. McKeown June 08, 2020
News Daily News Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades Yael L. Maxwell May 28, 2020
News Conference News ACC 2020 Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH Yael L. Maxwell April 06, 2020
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Conference News ACC 2020 Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients L.A. McKeown April 01, 2020
News Conference News ACC 2020 Evinacumab Cuts LDL Cholesterol in Homozygous FH Yael L. Maxwell April 01, 2020
News Daily News COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say Todd Neale March 17, 2020
News Daily News LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure Shelley Wood March 10, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis Caitlin E. Cox February 07, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020